Jim Wassil - Sep 8, 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: CHIEF OPERATING OFFICER
Signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol: PCVX
Transactions as of: Sep 8, 2025
Transactions value $: -$89,419
Form type: 4
Date filed: 9/10/2025, 04:27 PM
Previous filing: Sep 4, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wassil Jim	CHIEF OPERATING OFFICER	C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS	Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact	2025-09-10	0001813798

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Tax liability	-$89.4K	-2.76K	-1.91%	$32.41	142K	Sep 8, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2	The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On September 9, 2025, the Reporting Person transferred 1,663 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.

Content

Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.

The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On September 9, 2025, the Reporting Person transferred 1,663 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.